Predicting Cognitive Deficits

Parkinson’s disease is commonly thought of as a movement disorder, but after years of living with the disease, approximately 25 percent of patients also experience deficits in cognition that impairs function. A newly developed research tool may help predict a patient’s risk for developing dementia and could enable clinical trials aimed at finding treatments to prevent the cognitive effects of the disease. …Continue reading

Startup Effectively Using AI

The explosion of new data regarding the biology of disease has far outpaced the human ability to consume and make sense of it which is creating a challenge for scientists working to translate biomedical data into new treatments. Uncovering potential new therapeutic indications for drugs powered by Artificial Intelligence (AI) is still rare in today’s drug development process. …Continue reading

Achieving Better Healthcare

Robert Pearl MD, Executive Director and Chairman of the Council of Accountable Physician Practices (CAPP) http://accountablecaredoctors.org, former CEO for The Permanente Medical Group, and former CEO for the Mid-Atlantic Permanente Medical Group, presented his unique perspective on the business of healthcare and the culture of medicine at the recent 9th Annual mHealth +Telehealth World meeting www.worldcongress.com. …Continue reading